Office of Biotechnology Activities; Office of Science Policy; Office of the Director; Notice of a Meeting of the NIH Blue Ribbon Panel, 2549 [2010-730]

Download as PDF Federal Register / Vol. 75, No. 10 / Friday, January 15, 2010 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Health Center Program AGENCY: Health Resources and Services Administration, HHS ACTION: Notice of Noncompetitive Replacement Award to Regional Health Care Affiliates. SUMMARY: The Health Resources and Services Administration (HRSA) will be transferring Health Center Program (section 330 of the Public Health Service Act) funds originally awarded to Trover Health System to Regional Health Care Affiliates to ensure the provision of critical primary health care services to underserved populations in Webster and McLean Counties, Kentucky. SUPPLEMENTARY INFORMATION: Former Grantee of Record: Trover Health System. Original Period of Grant Support: June 1, 2009 to February 28, 2011. Replacement awardee: Regional Health Care Affiliates. Amount of Replacement Award: $17,000. Period of Replacement Award: The period of support for the replacement award is September 1, 2009, to February 28, 2011. jlentini on DSKJ8SOYB1PROD with NOTICES Authority: Section 330 of the Public Health Service Act, 42 U.S.C. 245b. CFDA Number: 93.224. Justification For The Exception To Competition: Under the original grant application approved by HRSA, Regional Health Care Affiliates (RHCA) was identified as the provider of health care services on behalf of the Trover Health System, while Trover Health System was to serve in an administrative capacity for the grant. After the award was issued, Trover Health System and RHCA notified HRSA that RHCA’s organizational structure had changed to enable it to carry out both administrative and programmatic requirements. The two parties requested that full responsibility for the grant be transferred from Trover Health System to RHCA. RHCA provided documentation that it meets Section 330 statutory and regulatory requirements as well as applicable grant management requirements. Regional Health Care Affiliates will directly initiate primary health care services in Webster and McLean Counties to the more than 5,250 low income, underserved and uninsured individuals in the original service area, Webster and McLean Counties, KY, as VerDate Nov<24>2008 17:34 Jan 14, 2010 Jkt 220001 had been proposed in funded grant application. Regional Health Care Affiliates can provide primary health care services immediately, is located in the same geographical area where the Trover Health System’s primary health care services have been provided, and will be able to provide continuity of care to patients of the former grantee. This underserved target population has an immediate need for vital primary health care services and would be negatively impacted by any delay caused by a competition. As a result, in order to ensure that critical primary health care services are available to the original target population in a timely manner, this replacement award will not be competed. FOR FURTHER INFORMATION CONTACT: Marquita Cullom-Stott via email at MCullom-Stott@hrsa.gov or 301–594– 4300. Dated: January 11, 2010. Mary K. Wakefield, Administrator. BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of Biotechnology Activities; Office of Science Policy; Office of the Director; Notice of a Meeting of the NIH Blue Ribbon Panel The purpose of this notice is to inform the public about a meeting of the NIH Blue Ribbon Panel to Advise on the Risk Assessment of the National Emerging Infectious Diseases Laboratories at Boston University Medical Center. There will be a meeting of the NIH Blue Ribbon Panel to advise on the Risk Assessment of the National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University Medical Center. The meeting will be held on Friday, February 12, 2010, at the Hyatt Regency Bethesda Hotel, located at 7400 Wisconsin Avenue, Bethesda, Maryland 20814, from approximately 8:30 a.m. to 2 p.m. This meeting is the second in a series of public meetings with the National Research Council to review the ongoing supplementary risk assessment study. Sign up for public comment will begin at approximately 8 a.m. In the event that time does not allow for all those interested in presenting oral comments, anyone may file written comments using the following address below. Fmt 4703 Sfmt 4703 Dated: January 11, 2010. Kelly R. Fennington, Special Assistant to the Director, Office of Biotechnology Activities, National Institutes of Health. [FR Doc. 2010–730 Filed 1–14–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [Docket No. FDA–2009–N–0604] Clinical Accuracy Requirements for Point of Care Blood Glucose Meters; Public Meeting; Request for Comments AGENCY: Food and Drug Administration, HHS. National Institutes of Health Frm 00075 An agenda and slides for the meeting can be obtained prior to the meeting by connecting to https:// nihblueribbonpanel-bumcneidl.od.nih.gov/. For additional information concerning this meeting, contact Ms. Laurie Lewallen, Advisory Committee Coordinator, Office of Biotechnology Activities, Office of Science Policy, Office of the Director, National Institutes of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892–7985; telephone 301–496– 9838; e-mail lewallenl@od.nih.gov. Food and Drug Administration [FR Doc. 2010–673 Filed 1–14–10; 8:45 am] PO 00000 2549 ACTION: Notice of public meeting; request for comments. The Food and Drug Administration (FDA) is announcing a public meeting entitled: Clinical Accuracy Requirements for Point of Care Blood Glucose Meters. The purpose of the public meeting is to discuss the clinical accuracy requirements of blood glucose meters and other topics related to their use in point of care settings. Dates and Times: The public meeting will be held on March 16, 2010, from 9 a.m. to 5 p.m. and on March 17, 2010, from 9 a.m. to 3:40 p.m. Location: The public meeting will be held at the Hilton Hotel in Gaithersburg, MD, 620 Perry Pkwy., Gaithersburg, MD 20877. For directions, please refer to the meeting Web page at https:// www.fda.gov/MedicalDevices/News Events/WorkshopsConferences/ ucm187406.htm. Contact Person: Arleen Pinkos, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5618, Silver Spring, MD 20993, 301–796– 6152, FAX: 301–847–8573, e-mail: Arleen.Pinkos@fda.hhs.gov. Registration: Persons interested in attending the meeting must register by February 15, 2010. If you wish to attend this public meeting, you must register E:\FR\FM\15JAN1.SGM 15JAN1

Agencies

[Federal Register Volume 75, Number 10 (Friday, January 15, 2010)]
[Notices]
[Page 2549]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-730]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities; Office of Science Policy; 
Office of the Director; Notice of a Meeting of the NIH Blue Ribbon 
Panel

    The purpose of this notice is to inform the public about a meeting 
of the NIH Blue Ribbon Panel to Advise on the Risk Assessment of the 
National Emerging Infectious Diseases Laboratories at Boston University 
Medical Center.
    There will be a meeting of the NIH Blue Ribbon Panel to advise on 
the Risk Assessment of the National Emerging Infectious Diseases 
Laboratories (NEIDL) at Boston University Medical Center. The meeting 
will be held on Friday, February 12, 2010, at the Hyatt Regency 
Bethesda Hotel, located at 7400 Wisconsin Avenue, Bethesda, Maryland 
20814, from approximately 8:30 a.m. to 2 p.m. This meeting is the 
second in a series of public meetings with the National Research 
Council to review the ongoing supplementary risk assessment study.
    Sign up for public comment will begin at approximately 8 a.m. In 
the event that time does not allow for all those interested in 
presenting oral comments, anyone may file written comments using the 
following address below.
    An agenda and slides for the meeting can be obtained prior to the 
meeting by connecting to https://nihblueribbonpanel-bumc-neidl.od.nih.gov/. For additional information concerning this meeting, 
contact Ms. Laurie Lewallen, Advisory Committee Coordinator, Office of 
Biotechnology Activities, Office of Science Policy, Office of the 
Director, National Institutes of Health, 6705 Rockledge Drive, Room 
750, Bethesda, MD 20892-7985; telephone 301-496-9838; e-mail 
lewallenl@od.nih.gov.

    Dated: January 11, 2010.
Kelly R. Fennington,
Special Assistant to the Director, Office of Biotechnology Activities, 
National Institutes of Health.
[FR Doc. 2010-730 Filed 1-14-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.